Literature DB >> 35347683

Establishment of Embryonic Zebrafish Xenograft Assays to Investigate TGF-β Family Signaling in Human Breast Cancer Progression.

Chao Li1, Jin Ma1, Arwin Groenewoud2, Jiang Ren1, Sijia Liu1, B Ewa Snaar-Jagalska2, Peter Ten Dijke3.   

Abstract

Transforming growth factor-β (TGF-β) family members have pivotal functions in controlling breast cancer progression, acting not only on cancer cells but also on other cells within the tumor microenvironment. Here we describe embryonic zebrafish xenograft assays to investigate how TGF-β family signaling controls breast cancer cell intravasation, extravasation and regulates tumor angiogenesis. Fluorescently mCherry-labeled breast cancer cells are injected in the perivitelline space or Duct of Cuvier of Tg (fli:EGFP) transgenic Casper zebrafish embryos, in which the zebrafish express enhanced green fluorescent protein in the entire vasculature. The dynamic responses of migratory and invasive human cancer cells, and the induction of new blood vessel formation by the cancer cells in zebrafish host, are visualized using a fluorescent microscope. These assays provide efficient, reliable, low-cost models to investigate the effect of (epi)genetic modulators and pharmacological compounds that perturb the activity of TGF-β family signaling components on breast cancer cell metastasis and angiogenesis.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Angiogenesis; Bone morphogenetic protein; Duct of Cuvier; Human breast cancer; Invasion; Perivitelline space; Signaling; Transforming growth factor-β; Zebrafish embryo

Mesh:

Substances:

Year:  2022        PMID: 35347683     DOI: 10.1007/978-1-0716-2277-3_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

Review 1.  Fish tales: The use of zebrafish xenograft human cancer cell models.

Authors:  Yvette Drabsch; B Ewa Snaar-Jagalska; Peter Ten Dijke
Journal:  Histol Histopathol       Date:  2016-12-09       Impact factor: 2.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.